InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: zumantu post# 3587

Saturday, 03/30/2013 9:00:03 AM

Saturday, March 30, 2013 9:00:03 AM

Post# of 426487
This anti-inflammatory effect of EPA may contribute to suppression of chronic inflammation...

Those of you looking for a reason to invest in AMRN should look into the very convincing evidence that EPA is the important component of "fish oil"-Omega3s, the key, in terms of moderating chronic inflammation...the dark hand that is behind so many of our degenerative diseases such as diabetes and atherosclerosis..

Since the late 1940s the incidence of Atherosclerosis has climbed steadily.
According to the NIH..." Clinical manifestations of atherosclerosis, including coronary artery disease, cerebrovascular disease, and peripheral arterial disease, will occur in 2 of 3 men and 1 in 2 women after age 40. [1] Almost 60% of deaths are due to a cardiovascular disease (CVD) cause. Atherosclerosis is a chronic, progressive disease with a long asymptomatic phase. [2] Subclinical atherosclerosis is a latent precursor of clinical CVD, including myocardial infarction (MI) and stroke."

http://www.biomedcentral.com/1471-2261/9/46

The climb in this disease can be traced to the increase of Omega6 PUFAs in our diet...resulting from two events dating back to the 1940s..The first event was a refined method of extracting oil from seed sources. The second being large scale grain feeding to livestock..These two changes by themselves have greatly increased the amounts of Omega6s in our diet chiefly Linoleic which is a precursor to Arachidonic Acid, the principal pro inflamatory agent in the all important Eicosanoid system that sets the activity level of the inflammatory system...The biggest health problem in the country, population wise, is our inflammatory systems are too active because our diet is too high in Omega6s..

One solution is we could eat less Omega6s...This is a non starter, since almost all elements of typical Americans are loaded with Omega6s and to change this would require a revolution..Vascepa enters this equation, because EPA turns out to be the most effective counter to the pro inflammatory effects of Omega6s..Think of the inflammatory system as a modification of the coagulation system...Patients with clotting problems are treated with coumadin or heparin, Think of EPA as the heparin of inflammation..

So Vascepa is totally undervalued because it is being looked at as a drug which lowers triglycerides..lowering triglycerides is actually one of its trivial benefits...So far the FDA has forced Amarin to keep the wraps on Vascepa's anti Omega6 properties...But these are where the true value lies..

Get the word out...

Happy Easter...":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News